Status:
TERMINATED
Pulmonary Embolism and PCT. PE-PCT Study
Lead Sponsor:
University Hospital, Clermont-Ferrand
Collaborating Sponsors:
Thermo Fisher Scientific, Inc
Conditions:
Pulmonary Embolism With Fever
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The clinical manifestations of pulmonary embolism vary greatly from the absence of specific clinical symptoms to cardiogenic shock or cardiac arrest. Clinical form of EP represented by "lung superinfe...
Detailed Description
The investigators propose to realize a single-center prospective, randomized, parallel group, to compare two groups of patients admitted with febrile pulmonary embolism . In the first group of patient...
Eligibility Criteria
Inclusion
- Age over 18 years
- CT diagnosis of pulmonary embolism
- Temperature\> 37.8 ° C
- About affiliated to the social security
- Prior agreement with the patient signing a consent
Exclusion
- Pregnant Woman
- Refusal of the patient
- Pulmonary Neoplasia
- Antibiotic ongoing for more than 24 hours at the time of diagnosis of pulmonary embolism
- Cardiogenic shock (hypotension with mean arterial pressure less than 65 bpm)
- Suspicion of infection other than lung associated (associated urinary tract infection, prostatitis, ENT infection, sinusitis ...)
- Patient under guardianship
- Patients unable to give consent
Key Trial Info
Start Date :
November 26 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 24 2019
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT02261610
Start Date
November 26 2014
End Date
November 24 2019
Last Update
April 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63003